Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Physics in medicine and biology · 2022
    NANikolaos A. KarakatsanisSASadek A Nehmeh
    PMID: 35472757DOISenior author23 citations
  2. 2
    Medical physics · 2020
    NANikolaos A. KarakatsanisSASadek A Nehmeh
    PMID: 31985827DOISenior author41 citations
  3. 3
    EJNMMI physics · 2024
    XHXiuyuan Hugh WangYLYi LiSASadek A Nehmeh
    PMID: 39331199PMCID: PMC11436579DOISenior author1 citations

Publications

86 publications

Funding

17 grantsView NIH portfolio on RePORTER ↗

Active

5 grants
  • MPI
    Dual-[Hypoxia+Proliferation] PET as a Predictive Biomarker in Recurrent Glioblastoma
    National Cancer Institute · 2026–2031
    R01CA308323-01A1
  • PI
    Ultra-High Performance Brain-dedicated PET scanner for Neurology and Neuro-oncology imaging
    National Cancer Institute · 2023–2028
    R01CA275942-04
  • KP
    Modernization and Expansion of the Citigroup Biomedical Imaging Center at Weill Cornell Medical College
    Office of the Director, NIH · 2023–2027
    C06OD036045-01
  • Co-I
    Perimenopause in Brain Aging and Alzheimer's disease
    National Institute on Aging · 2021–2026 · via University of Arizona
    P01AG026572-16
  • KP
    New PET/CT System for Human and Non-human Primate Imaging
    Office of the Director, NIH · 2023–2026
    S10OD034271-01
Completed grants (12)
  • Co-I
    MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)
    National Heart, Lung, and Blood Institute · 2019–2025
    R01HL144541-05
  • Co-I
    Identifying mechanisms of tissue injury in MS lesions: a multi-modality imaging approach
    National Institute of Neurological Disorders and Stroke · 2018–2024
    R01NS104283-01A1
  • Co-I
    Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's Disease
    National Institute on Aging · 2021–2024
    R01AG072753-01A1
  • Co-I
    Sex Differences in the Molecular Determinants of Alzheimer’s Disease Risk
    National Institute on Aging · 2018–2024 · via University of Arizona
    R01AG057931-01A1
  • Co-I
    The Development of Radiolabeled Positional isomers of [11C]Pyruvate for Imaging Cancer Metabolism
    National Institute of Biomedical Imaging and Bioengineering · 2020–2024
    R21EB029649-03
  • Co-I
    CSF clearance and brain amyloid dynamics after traumatic brain injury
    National Institute of Neurological Disorders and Stroke · 2019–2023
    R56NS111052-01
  • Co-I
    Predictive Model of Spread of Parkinson's Pathology Using Network Diffusion
    National Institute of Neurological Disorders and Stroke · 2016–2023
    R01NS092802-01A1
  • Co-I
    PET Imaging Biomarkers to Predict Cardiac Remodeling and Functional Decline in Cardiotoxicity Arising from Chemotherapy
    National Cancer Institute · 2019–2022
    R21CA246409-01
  • Co-I
    CSF Clearance with 11C-Butanol PET Predicts Amyloid Deposition
    National Institute on Aging · 2018–2022· 2 renewals
    R56AG058913-02
  • Co-I
    PET Measures of CSF Clearance in Preclinical Alzheimer's Disease
    National Institute on Aging · 2017–2022· 2 renewals
    RF1AG057570-02
  • Co-I
    Understanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's Disease
    National Institute on Aging · 2019–2021
    R56AG064873-01
  • MPI
    Prognostic value of tumor hypoxia, as measured by 18F-FMISO Breath Hold PET/CT
    NCI · 2012–2015 · via NIH RePORTER
    U01CA157442-02

Clinical research

2 studies

Active

1 study
  • PI
    Ultra-High Performance Brain-dedicated PET scanner for Neuroimaging in Alzheimerâ s Disease
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
Completed & closed trials (1)
  • PI
    A Phase-I Trial for Simultaneous Imaging of Tumor Hypoxia and Proliferation in Patients With Treatment- Naïve High-Grade Glioma
    PHASE1 · Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2025)
    Glioma
    NCT04309552